Active Molecules (Inhibitors, Pharmaceuticals, APIs)

Signaling Pathway Anti-infectionAntibody-drug Conjugate/ADC RelatedApoptosisAutophagyCell Cycle/DNA DamageCytoskeletonEpigeneticsGPCR/G ProteinImmunology/InflammationJAK/STAT SignalingMAPK/ERK PathwayMembrane Transporter/Ion ChannelMetabolic Enzyme/ProteaseNeuronal SignalingNF-κBOthersPI3K/Akt/mTORPROTACProtein Tyrosine Kinase/RTKStem Cell/WntTGF-beta/Smad

Clinical Trial DiscontinuedDiscoveryLaunchedNo Development ReportedPhase 1Phase 2Phase 3Phase 4Pre-registrationSuspendedWithdrawn

Diseases and Conditions Cancer Cardiovascular Disease Endocrinology Infection Inflammation/Immunology Metabolic Disease Neurological Disease Others

Raw Materials

Intermediates

ChemWerth, Inc.

0	Basic Information Company Name:ChemWerth, Inc. Business Type:Chemical manufacturer since 1982 Total NO.Employees: Country/Region:USA Certificates: Year Established: